METHOD OF TREATING CANCER WITH AN IMMUNE CHECKPOINT INHIBITOR IN COMBINATION WITH ANOTHER THERAPEUTIC AGENT

摘要

A method and a kit are provided for predicting a favorable or a non-favorable response of a cancer patient to treatment with a cancer therapy by determining in a biological sample obtained from the cancer patient, before and after the treatment, the changes of the levels of factors/biomarkers generated by the cancer patient in response to said treatment, and a method for treatment of a cancer patient.